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TolC is an archetypal member of the outer membrane efﬂux protein (OEP) family. These
proteins are involved in export of small molecules and toxins across the outer membrane
of Gram-negative bacteria. Genomes of some bacteria such as Pseudomonas species con-
tain multiple copies of OEPs. In contrast, enterobacteria contain a single tolC gene, the
product of which functions with multiple transporters. Inactivation of tolC has a major
impact on enterobacterial physiology and virulence. Recent studies suggest that the role
of TolC in physiology of enterobacteria is very broad and affects almost all aspects of cell
adaptation to adverse environments. We review the current state of understanding TolC
structure and present an integrated view of TolC function in enterobacteria. We propose
that seemingly unrelated phenotypes of tolC mutants are linked together by a single most
common condition – an oxidative damage to membranes.
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DIVERSITY AND DISTRIBUTION OF TolC-LIKE CHANNELS IN
GRAM-NEGATIVE BACTERIA
The important role of TolC in the structure and function of the
outer membrane of E. coli is known for at least 30 years (Morona
and Reeves, 1981, 1982; Morona et al., 1983). The early obser-
vations that tolC mutants are tolerant to colicin E1 and at the
same time hypersensitive to certain dyes, drugs and detergents led
to the conclusion that these mutants have alterations in the cell
membrane. Later studies established that TolC and its homologs
in other Gram-negative bacteria enable transport of various toxic
molecules across the outer membrane (Benz et al., 1993; Fralick,
1996).
TolC belongs to the outer membrane efﬂux proteins (OEP)
family (or “Outer Membrane Factor” family), members of which
function in conjunction with three types of transport systems:
ATP-binding cassette (ABC)-type, resistance nodulation division
(RND)-type, and major facilitator superfamily (MF-type; Paulsen
et al., 1997). The association between transporters and OEPs is
mediated by periplasmic proteins named membrane fusion pro-
teins (MFPs; Dinh et al., 1994; Zgurskaya et al., 2009). A structural
model depicting a proposed arrangement of OEPs with the inner
membrane permeases and periplasmic MFPs using the example of
AcrAB–TolC is shown on Figure 1. The characteristic feature of
this model is that TolC and other OEPs span the outer membrane
and protrude deep into the periplasm.
Sequence analyses of OEPs showed that they are highly diver-
gent with only two subtle common motifs (Johnson and Church,
1999). These motifs belong to the structural signature of OEPs –
their coiled-coil regions (Figure 2; Koronakis et al., 2000). The
characterizedOEPs cluster into three clades corresponding to their
broadly deﬁned efﬂux functions: (i) the multidrug efﬂux, where
the best characterized representative is Pseudomonas aeruginosa
OprM, (ii) the cation efﬂux with E. coli CusC as a typical rep-
resentative, and (iii) the protein export (type I secretion system)
represented by E. coli TolC (Hatfaludi et al., 2008). Perhaps as a
result of such functional specialization,genomes of Gram-negative
bacteria usually contain several OEP genes.
Four OEPs were identiﬁed in E. coli genome: tolC, yjcP (mdtP),
yohG (mdtQ), and ylcB (cusC ; Sulavik et al., 2001). Inactivation
of tolC leads to signiﬁcant increase in susceptibility to multiple
anti-bacterial agents suggesting that TolC is the major conduit
for multidrug efﬂux across the outer membrane of E. coli (Fral-
ick and Burns-Keliher, 1994; Sulavik et al., 2001). In addition,
tolC is required for export of plasmid-encoded and chromosomal
toxins such as hemolysin, colicin V, and microcins (Wandersman
and Delepelaire, 1990; Hwang et al., 1997; Delgado et al., 1999).
Deletions of yjcP and yohG did not affect the intrinsic levels of
antibiotic resistance but cells lacking these genes were slightly
more susceptible to puromycin, an antibiotic inhibiting protein
translation (Sulavik et al., 2001). CusC is produced in a single
operon with cusBA genes and is implicated in resistance against
Cu(I)/Ag(I) ions generated under anaerobic conditions (Franke
et al., 2003).
In comparison, P. aeruginosa (Pae) genome contains 18 OEPs
(Jo et al., 2003). Phylogenetic analyses revealed that these OEPs
could be subdivided into two subfamilies: the OprM subfamily
comprising 11 highly homologous channels involved in multidrug
efﬂux and the more divergent AprF protein export subfamily,
which also includes OpmH and OpmM. The type I secretion pro-
tein AprF and OpmH are the most closely related to E. coli TolC.
However, it is the OprM channel, which is constitutively expressed
and confers the intrinsic resistance of P. aeruginosa to a wide
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FIGURE 1 | A proposed mechanism of AcrAB–TolC efflux pump
(modified fromTikhonova et al., 2011).The tri-partite complex is
assembled between the pre-assembled inner membrane (IM) complex
AcrAB and the closed outer membrane (OM) channel TolC. Kinetic studies
suggest that TolC binds directly to AcrB followed by engagement of AcrA.
But an alternative order where AcrA binding to TolC precedes AcrB–TolC
interaction cannot be excluded at this point. Docking of AcrA α-hairpins onto
TolC coiled-coil domain leads to conformational changes in the membrane
proximal domain of AcrA, which are needed for stimulation of AcrB transport
activity. The activated AcrAB transporter triggers opening of the periplasmic
tip of TolC to allow diffusion of substrates across the outer membrane. The
open conformation of the complex is short-lived and relaxes into the closed
state with or without dissociation of AcrA α-hairpins fromTolC.
FIGURE 2 | Structure and mechanism ofTolC. (A) Ribbon representation
of TolC homotrimer (side view) with key domains indicated (reproduced
from Zgurskaya et al., 2009 with permission from Elsevier). A monomer of
TolC is highlighted in red. (B)The proposed mechanism of TolC transition
into the open state (reproduced from Koronakis, 2003 with permission from
Elsevier). Space-ﬁlled (upper) and ribbon (lower) depictions of the closed
and modeled open states of the tunnel entrance, viewed from the
periplasm. The coiled-coils H3/H4 and H7/H8 of one protomer are colored
and show the constraining intramonomer (I and II) and intermonomer (III)
links.
spectrum of toxic compounds (Li et al., 1995). Mutational inac-
tivation of other OEPs does not usually lead to dramatic changes
in susceptibility (Chuanchuen et al., 2005). However, when over-
produced in the absence of OprM, either OpmJ or OpmH confer
resistance to a broad range of antimicrobials, complementing or
even exceeding the spectrum of OprM (Jo et al., 2003). This and
other studies suggested that division of OEPs based on substrate
speciﬁcities is limited to their sequence homologies with most of
OEPs able to transport a variety of substances across the outer
membrane.
The ability to translocate a given substrate by an OEP depends
on its versatility in association with transporters. TolC functions
with the majority of MFP-dependent transporters encoded in the
genome of E. coli, an exception is a cation transporter CusBA,
which functions with CusC (Nishino and Yamaguchi, 2001). Sim-
ilar requirements for TolC were described in Salmonella, Vibrio,
Klebsiella, and others species (Bina and Mekalanos, 2001; Barabote
et al., 2003; Gil et al., 2006; Cosme et al., 2008; Al-Karablieh et al.,
2009; Fenosa et al., 2009; Ferhat et al., 2009;Horiyama et al., 2010).
The multi-functionality is also reﬂected by the fact that the tolC
gene in these organisms is transcribed independently from the
inner membrane counterparts and its genetic context is conserved
only in the closely related species (i.e., all Enterobacteriaceae).
On the other side of the OEP spectrum are specialized cation
efﬂux and type I secretion OEPs that function exclusively with
speciﬁc transporters. These OEPs are usually expressed in gene
clusters along with the inner membrane components of the com-
plex. However, even these specialized OEPs demonstrate certain
promiscuity. For example, Serratia marcescens contains several
type I secretion systems, which export such proteins as the lipase
LipA, the metalloprotease PrtA, and the heme-binding protein
HasA (Letoffe et al., 1993, 1994; Akatsuka et al., 1995). Studies
of hybrid transporters demonstrated that OEPs do not possess
any substrate speciﬁcity and their involvement in transport reac-
tions is determined by their ability, or the lack of such, to bind
an inner membrane complex. In general the substrate speciﬁcity
of the complex appears to be determined by the inner membrane
complex (Akatsuka et al., 1997).
STRUCTURE, FOLDING, AND ASSEMBLY OF TolC IN THE
OUTER MEMBRANE
The structure of TolC solved by Koronakis et al. (2000) was fol-
lowed by high-resolution structures of CusC, P. aeruginosa OprM,
and Vibrio cholerae VceC (Akama et al., 2004; Federici et al.,
2005; Phan et al., 2010; Kulathila et al., 2011). Despite very low
sequence similarity between these proteins, their structures are
dramatically similar and unique among outer membrane proteins
(OMPs; Andersen et al., 2001). Extending from the extracellular
spacewell into the periplasm,TolC is a 140-Å long, cannon-shaped
protein made up of a 12-stranded β-barrel, an α-helical domain,
and a mixed α/β equatorial domain (Figure 2A; Koronakis et al.,
2000). The β-barrel of TolC is a trimer embedded into the outer
membrane, where each protomer contributes only a third of the
β-strands. In contrast, in a typical OMP each protomer is folded
into a β-barrel (Delcour, 2002). The α-domain is made up of two
longhelices, that span the nearly 100Å into the periplasm,and four
shorter helices that stack up to make two long, pseudo-continuous
helices spanning the length of the entire α-domain as well. The
dense packing of the three curved sets of coiled-coils has been
proposed to keep the periplasmic opening of TolC in its “closed”
conformation (Figure 2B). Still, the cavity of TolC is one of the
largest known among protein structures, holding about 43,000 Å
of solvent and it is capable of allowing passage of particles as large
as 160 kDa (Andersen et al., 2001).
The unique structure of TolC suggested that its folding and
assembly into the outer membrane are likely also to be distinct
from other OMPs (Werner et al., 2003). Two basic models are pro-
posed for the OMP assembly. The most experimentally supported
model postulates that nascent polypeptides of OMPs are deposited
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in their soluble state into the periplasm. In the alternative model,
OMP polypeptides remain weakly associated with the inner mem-
brane as they reach the outer membrane via membrane contact
sites (reviewed in Hagan et al., 2011). TolC, like other proteins, is
synthesized in the cytoplasmof E. coli and is transported across the
inner membrane into the periplasm. Cytoplasmic chaperones of
the Sec machinery target the cleavable N-terminal signal peptide
of the protein and aid with its translocation. The cleavage of the
signal peptide yields a mature, 471-amino acid TolC, which folds
and assembles in the periplasm. Studies from Misra’s group sug-
gested that TolC, like other OMPs, emerges into the periplasm as a
soluble intermediate sensitive to proteinaseK (Werner et al., 2003).
However, unlike otherOMPs, the assembly of TolC trimers is inde-
pendent from known periplasmic chaperones such as SurA, Skp,
and DegP, as well as lipopolysaccharides. This ﬁnding implied that
TolC either folds in a unique manner or uses unique factors. How-
ever, a signal sequence-less mature TolC folds and forms trimers
even in the cytoplasm suggesting that no external factors are
required (Masi et al., 2009). The large α-helical coiled-coil domain
likely enables the protein to stay in the soluble state without help
from the periplasmic chaperones.
Theﬁnal step in the assemblyof TolC, its insertion into theouter
membrane, remains largely unclear. In E. coli, assembly of β-barrel
OMPs including TolC is facilitated by the ﬁve-protein BamABCDE
complex. In this complex, BamA and BamD are essential for cell
growth (reviewed in Hagan et al., 2011). The periplasmic portion
of BamA comprising the ﬁve POTRA (polypeptide translocation
associated) domains is shown to receive unfolded OMPs from
periplasmic chaperones. In addition, POTRA domains serve as
docking sites for the rest of Bam proteins. The trans-membrane
β-barrel domain of BamA is believed to provide a scaffold dur-
ing the ﬁnal insertion of OMPs into the membrane. The role of
BamD is less clear but it could assist BamA during the ﬁnal steps
of assembly of oligomeric OMPs or could facilitate dissociation of
a folded OMP from BamA.
Since folding in the periplasm and translocation of TolC to the
outer membrane do not require the known OMP chaperones, the
engagement of TolC by BamA is expected to differ from other
OMPs. Indeed, a recent study by Bennion et al. (2010) showed
that TolC bypasses not only the requirement for chaperones but
also the requirement for the ﬁrst POTRA domain of BamA. Since
assembly of TolC still requires functional BamA/BamD proteins,
theOMPs andTolCpathways seem tomerge at the later stages,per-
haps during insertion into themembrane. The process of insertion
and functional interactions that occur during assembly of OMPs
and TolC however remain unknown.
TRANSPORT MECHANISM OF TolC
The structure of TolC suggested a possible mechanism of trans-
port. The large periplasmic extension of TolC channel is thought
to be a docking site for MFPs and transporters. Since in crys-
tals the periplasmic entrance of TolC and other OEPs is tightly
closed so that even ions cannot easily diffuse through, the asso-
ciation with the inner membrane complex is thought to trigger
opening of TolC channel (reviewed in Koronakis, 2003). This crit-
ical step in transport across the outer membrane however has not
been yet successfully reconstituted in vitro. The proposed allosteric
opening mechanism envisages that the inner coiled-coil α-helices
(H7/H8) undergo an iris-like movement to realign with the outer
coils (H3/H4), thereby enlarging the pore in a “twist-to-open”
transition (Figure 2B). This hypothesis is supported by studies of
TolC mutants with disrupted network of constraining hydrogen
bonds (Andersen et al., 2002). The intra-protomer bond Y362–
R367 tethers the inner coiled-coil H7/H8 to the outer H3/H4
coiled-coils. Substitutions in these residues increase the conduc-
tance of TolC channel from the “closed” 80 pS to partially open
205–370 pS (R367S mutant) and maximum conductance of 800–
1000 pS in the double R367S Y362F TolC mutant (TolCYFRS). The
sequential open states were also found in crystal structures of these
TolC mutants supporting further the idea that destabilization of
ionic bonds in the periplasmic tip could dilate the TolC pore and
allow passage of substrates through the channel (Bavro et al., 2008;
Pei et al., 2011).
These studies raised several questions about the mechanism
of TolC. From the description above it is obvious that signiﬁcant
conformational changes in TolC are needed to undergo transition
into the open state. Whether association with the inner mem-
brane complex is sufﬁcient to trigger such transition is unclear. The
best currently available model of AcrAB–TolC complex postulates
TolC interactions with both AcrA and AcrB proteins (Symmons
et al., 2009). Detailed discussions of the assembly and mecha-
nism of AcrAB–TolC can be found in several recent review articles
(Misra and Bavro, 2009; Nikaido and Takatsuka, 2009; Pos, 2009;
Zgurskaya, 2009). The latest data indicate that AcrA andAcrB exist
in the inner membrane as a preformed complex and remain asso-
ciated with each other during TolC docking (Figure 1). It appears
that TolC can bind AcrB directly and that the tri-partite complex
is formed between AcrA and TolC engaged by AcrB (Tikhonova
et al., 2011). It is unclear however whether the same order of
interactions could be achieved in assembly of TolC-dependent
transporters belonging to ABC and MF families. Transporters of
these two families lack the sizable periplasmic domains of AcrB
and therefore are unlikely to bind TolC directly. In such complexes,
MFPs are thought to play the major role in both recruitment and
opening TolC.
Once the complex is assembled, all three export components
undergo conformational changes, which presumably lead to the
opening of TolC and extrusion of substrates (Symmons et al.,
2009). An extensive amount of research has been carried out to
reveal speciﬁc residues and regions important for the functional
interactions between TolC and the inner membrane complexes
(Stegmeier et al., 2006; Lobedanz et al., 2007; Krishnamoorthy
et al., 2008). Several independent studies converged onto a model,
in which MFPs bind TolC in stoichiometry six MFP to three TolC
(Tikhonova et al., 2009, 2011; Janganan et al., 2011; Su et al., 2011;
Xu et al., 2011a). The α-helical hairpins of MFPs play a critical
role in the assembly of the complex by docking onto the intra- and
inter-protomer grooves of TolC and forming a sheath-like struc-
ture surrounding the periplasmic tip of TolC (Figures 1 and 3A).
This model was recently challenged by ﬁndings that MFPs could
also interact with TolC in a tip-to-tip manner (Xu et al., 2011b). In
the latter case, MFPs extend the periplasmic tunnel-like structure
of TolC all the way into the inner membrane (Figure 3B). It is
presently unclear whether a tip-to-tip MFP–TolC complex is an
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FIGURE 3 |The modeled structure of AcrAB–TolC complex.Two
alternative interfaces between components of the complex are supported
by experimental data. In the ﬁrst model (A), AcrA α-hairpins dock into the
inter-and intra-protomer grooves of TolC coiled-coil domain andTolC directly
binds AcrB (reproduced from Eswaran et al., 2004 with permission from
Elsevier). In the alternative model (B), AcrA andTolC interact with each
other in a tip-to-tip manner, which would separate AcrB andTolC and
increase the inter-membrane length of the complex by about 40Å (Xu et al.,
2011a). A similar interaction was also proposed between MacA andTolC
(reproduced from Xu et al., 2010 with permission from Elsevier).
intermediate step during the assembly or is in fact, the only mode
of interaction between the two proteins.
It is clear however, that binding to TolC changes the con-
formation of a MFP. CvaA, a MFP functioning with TolC in
export of colicin V, is highly unstable and rapidly cleaved by
periplasmic proteases in cells lacking TolC (Hwang et al., 1997).
Similar changes in sensitivity to proteases were reported for the
hemolysin exporting HlyD (Thanabalu et al., 1998), multidrug
efﬂux AcrA, and macrolide efﬂux MacA (Ge et al., 2009; Modali
and Zgurskaya, 2011). In the case of AcrA and MacA, we demon-
strated that these conformational changes affect the membrane
proximal domain of the protein, which directly interfaces with the
transporter (Figure 1; Modali and Zgurskaya, 2011; Tikhonova
et al., 2011). We also proposed that TolC-dependent confor-
mational change in the membrane proximal domain of MFP
may be required for the complex assembly and activation of
the transporter (Modali and Zgurskaya, 2011; Tikhonova et al.,
2011).
The dramatic structural differences between RND, ABC, and
MF transporters imply that these transporters either do not have
any direct contact with TolC or that there is certain ﬂexibility in
how TolC is engaged into complexes. AcrB and other RND pumps
are likely to directly bind TolC and contribute to TolC opening
(Tamura et al.,2005;Bavro et al.,2008;Tikhonova et al.,2011). This
model is also compatible with structural features of RND pumps
such as the threefold symmetry and large periplasmic domains
matching the geometry of TolC periplasmic tip (Murakami et al.,
2002; Pos, 2009). In contrast, very little structural information
is available for ABC and MF pumps and the current assump-
tions are based on what we know about their TolC-independent
homologs. For the macrolide efﬂux ABC-type MacB and its close
homologs, direct interaction with TolC is still a possibility because
these transporters also possess large periplasmic domains with
structural features reminiscent of those of AcrB (Xu et al., 2009).
However, the type I secretion ABC transporters and MF trans-
porters seem to be unable to reach the periplasmic tip of TolC.
Therefore, in these complexes TolC opening is achieved exclusively
through the action of MFPs. Molecular details of such mechanism
remain unknown.
It is also unknown how conformational transitions in TolC
are integrated into reaction cycles. One possibility is that the
assembly of the trans-membrane complex stabilizes the open
conformation of TolC, so that the life-time of the complex and
the turnover number of the transporter determine the number
of substrate molecules translocated through TolC. In the type I
secretion systems, binding of substrate to the inner membrane
complex seems to trigger TolC recruitment and stabilization of its
open state (Thanabalu et al., 1998). However, TolC forms more
stable complexes with drug efﬂux transporters, which are inde-
pendent of the presence of substrates (Tikhonova and Zgurskaya,
2004).
Furthermore, kinetic analyses showed that mutational open-
ing of TolC decreases its afﬁnity to AcrAB suggesting that TolC
opening could actually trigger the disassembly of the complex
(Tikhonova et al., 2011). Such mechanism could explain how the
low permeability barrier of the outer membrane is maintained
during efﬂux. It is apparent that the open TolC channel would
be a signiﬁcant breech of the outer membrane permeability bar-
rier. Studies of vancomycin resistance in E. coli show that cells
containing functional AcrAB–TolC pump are more susceptible to
this antibiotic than cells lacking either AcrAB or TolC (Bavro et al.,
2008 and unpublished data). Since vancomycin is too large to cross
the outer membrane by diffusion, the explanation for this result is
that this antibiotic can slip through TolC engaged by AcrAB. One
could imagine that to limit the inﬂux of substrates through TolC,
the complex is assembled with the closed TolC conformer and that
the transition into the open state is triggered, for example, by sub-
strate binding, as proposed for CusBAC (Kim et al., 2011). In the
open state the complex is unstable and rapidly dissociates relaxing
TolC into its closed conformation (Figure 1).
In summary, the current models of TolC function in trans-
port across the outer membrane involve opening of the periplas-
mic entrance of TolC upon association with an inner membrane
complex. Despite the structural and functional diversity of inner
membrane complexes that depend on TolC for their activities, it
is likely that the same set of chemical bonds must be rearranged
during the switch of TolC into the open state. However, depending
on the transporter, the amino acid residues that participate in this
bonding and stabilize the open TolC conformation could belong
either to an inner membrane transporter, an MFP or both. How
long TolC stays in the open conformation will deﬁne the efﬁciency
of transport across the outer membrane. The fast disengagement
of TolC upon transition into the open state could be important to
maintain the permeability barrier of the outer membrane.
REGULATION OF TolC EXPRESSION
Although E. coli tolC gene is constitutively expressed at ∼1500
protein copies per cell (Tikhonova and Zgurskaya, 2004), its
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expression is further upregulated in response to at least six differ-
ent environmental signals. tolC is amember of themarA/soxS/ rob,
PhoPQ, BaeSR, and EvgAS regulons that promote resistance to
multiple antibiotics, to superoxides and are required for survival
under acidic conditions, extracytoplasmic stress, and during infec-
tions (Aono et al., 1998; Eguchi et al., 2003; Nishino et al., 2005;
Zhang et al., 2008). Four tolC promoters act to tune up TolC
levels to speciﬁc conditions (Zhang et al., 2008). The p1 pro-
moter has signiﬁcant constitutive expression under laboratory
conditions and is responsive to none of the above regulators.
The p2 promoter is responsive to EvgAS and PhoPQ but not
the others. The p3 and p4 promoters are activated by MarA,
SoxS, and Rob, with each activator being regulated by differ-
ent environmental signals. There is no a BaeR-binding motif
upstream of tolC suggesting that the effect of BaeR overproduc-
tion on upregulation of tolC could be indirect (Nishino et al.,
2005).
The environmental signal for EvgAS is not known but this reg-
ulator activates expression of multidrug efﬂux pumps and genes
required for survival at low pH (Masuda and Church, 2003).
BaeRS responds to indole, ethanol, EDTA, ﬂavonoids, and sodium
tungstate (Bury-Moné et al., 2009; Leblanc et al., 2011). PhoPQ
is activated by low pH and low Mg2+ concentrations, conditions
that exist in phagosomes (Groisman, 2001). Genes marA and soxS
are paralogs, transcription of which is activated by treating cells
with salicylate and paraquat, respectively, and the activity of Rob
can be increased post-transcriptionally by treatment with 2,2′-
Dipyridyl, bile salts and decanoate (Martin and Rosner, 2002). In
addition, MarA and SoxS transcription as well as Rob activity are
upregulated in tolC mutants (Rosner and Martin, 2009). These
multiple transcriptional regulatory elements possibly tailor a par-
ticular TolC function (efﬂux, protein secretion, acid resistance) to
different environments and by this means promote cellular adap-
tation and proliferation (Figure 4; Zhang et al., 2008). Regulation
of tolC in S. Typhimurium is similar to that in E. coli and involves
global regulators marA/soxS/rob as well as a transcriptional reg-
ulator RamA (Randall and Woodward, 2002; Nishino et al., 2006;
Webber et al., 2009).
ROLE OF TolC IN ENTEROBACTERIAL PHYSIOLOGY
It is well established that mutants lacking tolC have pleiotropic
phenotypes including increased susceptibility to antibiotics, cell
division defects, changes in the expression of outer membrane
porins, sensitivity to acid, decreased virulence, and others (see
below). At least some of these phenotypes could be explained by
the fact that deletion of tolC leads to upregulation of marA and
soxS transcription and Rob activity (Rosner and Martin, 2009).
For example, tolC mutants contain very low levels of OmpF porin,
which is downregulated via micF RNA activation by Rob (Morona
and Reeves, 1982; Misra and Reeves, 1987; Chubiz and Rao, 2011).
Other phenotypes are likely to arise because of the extensive
functional interactions involving TolC either directly or indirectly
(Figure 4).
ANTIBIOTIC RESISTANCE
Inactivation of tolC increases susceptibility of enteric bacteria to
an extremely broad spectrum of antimicrobial agents including
FIGURE 4 | Functional association network ofTolC in E. coli.TheTolC
network was generated using STRING database (http://string.embl.de). The
interactions include direct (physical) and indirect (functional) associations
derived from genomic context, high-throughput experiments,
co-expression, and literature mining. Stronger associations are represented
by thicker lines. Predicted functional partners of TolC are described in
Table A1 in Appendix. Three major functional clusters: (i) cell envelope, (ii)
efﬂux pumps, and (iii) metabolism are indicated.
antibiotics, detergents, dyes, organic solvents, and others (Sulavik
et al., 2001). This function of TolC is dependent on the activity of
efﬂux pumps. Usually bacteria express at least one“housekeeping”
efﬂux pump such as AcrAB in E. coli, which in association with
TolC reduces periplasmic concentrations of antibiotics (Nikaido,
2009). Drug susceptibilities of ΔacrAB and ΔtolC strains are
similar but not identical with the more severe phenotype in
cells lacking tolC (Sulavik et al., 2001). This difference could be
attributed to TolC association with other efﬂux pumps. How-
ever, besides acrAB, none of the conﬁrmed or putative multidrug
efﬂux pumps were found to contribute to the intrinsic resis-
tance. Therefore, other functions of TolC could be reﬂected in
the increased susceptibility of E. coli to antimicrobials as well. In
another survey of more than 10,000 phenotypes, the phenotypes
of tolC and acrB mutants correlated with each other (r = 0.78)
conﬁrming the functional link between these genes (Nichols et al.,
2011).
Increased efﬂux pump expression has been documented in
association with resistance to several antibiotic classes (reviewed
in references Poole, 2004; Piddock, 2006). Only AcrAB–TolC over-
production, however, has been shown to contribute to clinical
antibiotic resistance in E. coli and Salmonella species. Surprisingly,
no signiﬁcant correlation was found between overproduction of
acrAB and tolC. In one of the most recent study (Swick et al.,
2011), among 37 ﬂuoroquinolone-resistant clinical isolates of
E. coli, 22 overexpressed acrA and 25 overexpressed acrB more
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than 2 SD above the respective means for the ﬂuoroquinolone-
susceptible isolates. In contrast, only three ﬂuoroquinolone-
resistant isolates overexpressed tolC by approximately sevenfold.
Overall, the average tolC expression levels of the ﬂuoroquinolone-
susceptible and ﬂuoroquinolone-resistant clinical isolates did not
differ statistically. tolC did not correlate with either acrA or acrB
and it does not appear that tolC is overexpressed with acrAB
for acquisition of ﬂuoroquinolone resistance despite the abil-
ity of all three genes to respond to MarA regulation (Barbosa
and Levy, 2000). This result indicates that (i) there are signiﬁ-
cant regulation differences between tolC and acrAB operons and
(ii) amounts of TolC do not limit the drug efﬂux capacity of
cells.
EXPULSION OF METABOLITES
Recent studies established that the intra- and extra-cellular con-
centrations of severalmetabolites are affected by tolC. Hantke et al.
(2011) showed that ΔtolC cells require signiﬁcantly lower con-
centrations of cAMP to induce expression of catabolic enzymes.
Since∼90% of cAMP produced by intracellular adenylate cyclases
is found in the culture medium, authors propose that TolC is
involved in export of cAMP. However, no transporter was iden-
tiﬁed that could export cAMP through TolC leaving open the
question whether changes in cAMP concentrations are due to
export function of TolC or due to changes in the metabolic state
of the cells.
Similar observationswere reported for porphyrins and cysteine,
which when produced in excess, are toxic to cells and expelled into
the culture medium (Tatsumi and Wachi, 2008). Porphyrin is a
constituent of the heme and is a cofactor for cytochromes that
participates in oxidative phosphorylation (Zufferey et al., 1997).
When added exogenously, the precursor of porphyrin, d-amino
levulinic acid (ALA) stimulates porphyrin biosynthesis in both the
wild-type and tolC mutant cells. However, the tolC mutant grown
in the presence of ALA had accumulated a larger amount of por-
phyrin(ogen)s intracellularly, while the wild-type cells excreted
porphyrins into the medium (Tatsumi and Wachi, 2008). Authors
proposed that ALA incorporated into the cells was metabolized to
porphyrin(ogen)s, and the excess porphyrin(ogen)s were exported
by theTolC-dependent efﬂux system. Screening of mutants lacking
all known TolC-dependent pumps did not identify a transporter
involved in porphyrin efﬂux.
Presence of high levels of cysteine is toxic to cells as it pro-
motes oxidative DNA damage by driving Fenton reaction (Park
and Imlay, 2003) and also by inhibiting enzymes in the cysteine
biosynthetic pathway. In cysteine overproducers, TolC is impor-
tant for alleviation of the cysteine stress by presumably exporting
it out of the cell (Wiriyathanawudhiwong et al., 2009). As in the
case with porphyrins, no efﬂux pumps that partner with TolC to
excrete cysteine were identiﬁed. tolC mutants are also hypersen-
sitive to exogenous glutathione in the efﬂux independent manner
(Dhamdhere et al., 2010).
In addition, E. coli TolC was implicated in export of
siderophores that are required in iron acquisition (Bleuel et al.,
2005; Newton et al., 2010). Acquisition of iron in response to its
scarcity inside the cell has been attributed to enterobactin,which is
secreted into the medium and after sequestering iron transported
back into the cell as ferric-enterobactin. Deletion of tolC resulted
in the total loss of enterobactin export and iron acquisition.
ACID TOLERANCE
Several pieces of evidence link tolC expression to acid pH resis-
tance. E. coli, when challenged with very low pH responds by the
induction of the acid resistance factor, glutamate decarboxylase
gene (gadAB) expression (reviewed in Foster, 2004). The dele-
tion of tolC made the cells susceptible to acidic environment
(Deininger et al., 2011). EmrB and MdtB efﬂux pumps seem to
function with TolC to enable E. coli survival at extreme acidic pH.
However, tolC mutant, but not emrB or mdtB, lacked the expres-
sion of GadAB system and was impaired when grown in medium
at pH 6.0 or below. These ﬁndings suggested that requirement for
tolC in acid tolerance is not limited to its functions with EmrB and
MdtB (Deininger et al., 2011).
Consistent with its role in acid tolerance and being a member
of the EvgA acid resistance regulon, TolC shows acid-enhanced
expression in the E. coli proteome (Yohannes et al., 2004). Inter-
estingly, in F. tularensis, the tolC homolog is even expressed in
the same operon with gad (Gil et al., 2006). Assembly of TolC
into efﬂux complexes is stimulated by acidic pH suggesting that
the acid-dependent expression and MDR assembly could explain
the increased sensitivity of bacteria to many antibiotics above pH
7 (Tikhonova et al., 2009). It seems that both the export and
the regulatory functions of TolC are fully engaged under acidic
conditions.
CELL MEMBRANE INTEGRITY
Studies from this lab showed that the loss of TolC leads to meta-
bolic shutdown and growth defects of E. coli grown in a minimal
medium with glucose. We found that the cytoplasmic mem-
brane stress, depletion of essential metabolites, and alteration
in NAD+/NADH ratios are the reasons for the TolC-dependent
growth impairment (Dhamdhere andZgurskaya,2010). The tolC−
phenotype was partially rescued by YgiBC and YjfMC, which have
parallel functions independent from TolC. Surprisingly, the dele-
tionof tolC triggered activationof thePsp regulon,which responds
to the dissipation of protonmotive force by favoring anaerobic res-
piration of nitrate (Bury-Moné et al., 2009). The transcriptional
regulator PspF derepresses a number of genes including the tol-
pal trans-envelope complex, which is required to maintain cell
envelope integrity, regulator hyfR controlling expression of genes
responsible for the proton-translocating formate dehydrogenase
system and formate reductase and norW, which encodes a ﬂavore-
ductase important for nitric oxide reduction (Bury-Moné et al.,
2009). Activation of Psp regulon strongly suggests that under con-
ditions of aerobic growth in the presence of glucose, deletion of
tolC compromises the integrity of the inner membrane leading to
inactivation of NADH oxidases, and dissipation of proton motive
force (Dhamdhere and Zgurskaya, 2010). These results also sug-
gest that upregulation of SoxS, MarA, and Rob pathways in tolC
mutants (Rosner and Martin, 2009) could be directly in response
to the membrane stress and metabolic imbalance.
VIRULENCE AND PATHOGENESIS
Apart from its role in multidrug resistance and physiology,
TolC and its homologs have been implicated in the virulence
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and pathogenesis of enteropathogenic E. coli, Salmonella, Vib-
rio, Haemophilus, Francisella, Legionella, and other species (Stone
and Miller, 1995; Bina and Mekalanos, 2001; Barabote et al.,
2003; Trepod and Mott, 2004; van Amsterdam et al., 2005; Gil
et al., 2006; Nishino et al., 2006; Posadas et al., 2007; Reddy
et al., 2007; Cosme et al., 2008; Ferhat et al., 2009). Since during
establishment and propagation of infection, bacteria encounter
multiple stresses and challenges, the protective function of TolC in
multidrug efﬂux, acid tolerance, and membrane integrity plays
an important role. In addition, as a part of type I secretion
system, TolC is directly involved in delivery of various viru-
lence factors. Among characterized substrates of the type I sys-
tems are RTX toxins such as E. coli α-hemolysin, extracellular
enzymes (protease, lipases, glycanases) as well as surface pro-
teins (S-layer proteins; Akatsuka et al., 1997; Delepelaire, 1998).
These systems can be divided into two subtypes based on the
N-terminal vs. the C-terminal location of the secretion sig-
nal of the substrate (Delepelaire, 2004). However, the mecha-
nism of transport seems to be similar for all type I secretion
systems.
Perhaps the best studied type I system is E. coli HlyBD–TolC
exporting α-hemolysin. Encoded by hlyA gene, α-hemolysin is
110 kDa protein that exhibits cytolytic activity. It is expressed as
a pro-toxin and then converted into a cytolytic form by HlyC, an
acyltransferase (Trent et al., 1998).Once inside the host, hemolysin
cause lysis of red blood cells and release heme, which is a rich
source of iron for E. coli. Except for tolC, the hlyCABD genes are
arranged together in the sameoperon,wherehlyB encodes an inner
membrane ABC-type transporter and hlyD encodes a MFP. TolC
is recruited into the complex only when α-hemolysin is already
bound to HlyBD.
Screening of TolC mutants identiﬁed speciﬁc amino acid
residues that are important for secretion of α-hemolysin but not
for efﬂux of antibiotics (Vakharia et al., 2001). Surprisingly, TolC
mutants T140A and S257P secreted an enzymatically inactive
hemolysin suggesting that TolC not only provides a channel for
hemolysin to cross the outer membrane but also contributes to
the proper folding of the secreted protein.
Secretion of heat stable enterotoxins I (STI) and II (STII),
which cause diarrhea in hosts infected with the enterotoxigenic
E. coli, also requires TolC but the mechanism differs from that
of the type I system (Burgess et al., 1978; Aimoto et al., 1982).
Both STI and STII are synthesized as pre-proteins (Okamoto and
Takahara, 1990). Once the pre-ST toxins reach the periplasm
through the Sec machinery, the N-terminal signal sequence is
cleaved to give the pro-ST toxin (Okamoto and Takahara, 1990).
Further, the toxin is modiﬁed in the periplasm to a form that
can be secreted into the extracellular space (Yamanaka et al.,
1993). The role of TolC in the ST export from the periplasm
and across the outer membrane has been established in ear-
lier studies (Foreman et al., 1995; Yamanaka et al., 1998) but
the inner membrane complex that enables this TolC function
remained unknown until recently. It appears that the macrolide
efﬂux pump MacAB associates with TolC in the secretion of
enterotoxin STII but not STI (Yamanaka et al., 2008). How the
fully folded STII is secreted from the periplasm by MacAB–TolC
remains unclear.
Given the crucial role of TolC in secretion and cell protection,
it is not surprising that tolC mutants are attenuated in infec-
tion models. Stone and Miller (1995) showed that S. enteridis
TolC is required for virulence in murine infection model. S.
Typhimurium ability to invade and persist in mouse monocyte
macrophages, embryonic cells and colonization of chickens were
similarly affected when tolC was deleted from its chromosome
(Buckley et al., 2006). The authors proposed that the deletion
of tolC probably affected the ability of Salmonella to export
host antimicrobials in conjunction with AcrAB proteins. Web-
ber et al. (2009) demonstrated that AcrA, AcrB, and TolC are each
required for efﬁcient adhesion to and invasion of epithelial cells
and macrophages by Salmonella in vitro. Gene expression proﬁles
showed that this phenotype is a result of decreased expression
of numerous genes encoding proteins involved in pathogenicity
including chemotaxis and motility genes and 14 Salmonella path-
ogenicity island (SPI)-1-encoded type III secretion system genes,
including sopE, and associated effector proteins. Enteroaggrega-
tive E. coli (EAEC) adheres to the intestinal mucosa forming a
bioﬁlm and secretes toxins that causes severe diarrhea in the host.
Recently, it was shown that TolC deletion can prevent bioﬁlm for-
mation and aggregation of EAEC due to decreased hydrophobicity
of the bacterial surface suggesting the role of TolC in cell–cell adhe-
sion in aqueous medium and also in the reduced levels of ﬁmbriae
proteins (Imuta et al., 2008).
INTEGRATED VIEW OF TolC FUNCTION IN ENTEROBACTERIA:
A HYPOTHESIS
There is no doubt that inactivation of TolC impairs the cellular
capacity for detoxiﬁcation and repair. However, it seems unlikely
that TolC is directly involved in export of metabolites, for which
no MFP-dependent efﬂux pump could be identiﬁed. Given an
extensive functional network of TolC (Figure 4), multiple fac-
tors could lead to observed changes in enterobacterial physiology.
However, the described above seemingly unrelated phenotypes are
linked together by a single most common condition – an oxidative
damage to membranes (Imlay, 2008). (i) Growth defects of tolC
mutants are exaggerated by the aerobic glucose metabolism, low
pH, and starvation, the conditions generating the oxidative stress.
(ii) The activity of NADH oxidases, like NDH-I, is decreased in
tolC− cells leading to increased concentrations of NADH. Inhi-
bition of NADH oxidases and accumulation of NADH induces
formation of reactive oxygen species responsible for oxidative
stress. (iii) Oxidative damage in tolC mutants provides an expla-
nation for activation of marA/SoxS/rob and Psp responses in these
cells. (iv) Depletion of a proton motive force and the metabolic
shutdown increase the intracellular concentration of cAMP,which
cannot be exported because transport reactions are halted as well.
It is likely that activity of many secondary transporters is compro-
mised in tolC mutants leading to accumulation of intermediate
metabolites. (v) Porphyrins and cysteine, the two known metabo-
lites affected by TolC, cause oxidative stress in the presence of Fe2+
ions. Accumulation of either one in tolC mutant could further
contribute to the stress. (vi) TolC is the major factor in protec-
tion against bactericidal and redox-active antibiotics that not only
inhibit speciﬁc targets but also kill cells by generating reactive
oxygen species and damaging membranes (Kohanski et al., 2007).
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Finally, during infection the major challenge presented to bacterial
cells are reactive oxygen species. tolC mutants already defective in
detoxiﬁcation are further compromised by inability to deal with
oxidative stress, which could be an additional factor contributing
to attenuation.
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APPENDIX
Table A1 | Predicted functional partners ofTolC.
Gene name Gene number Function
mdtK 511145.b1663 Multidrug efﬂux system transporter; multidrug efﬂux pump that functions probably as a Na(+)/drug antiporter. Con-
fers resistance to many drugs such as ﬂuoroquinolones (norﬂoxacin, ciproﬂoxacin, enoxacin), tetraphenylphosphonium
ion (TPP), deoxycholate, doxorubicin, trimethoprim, chloramphenicol, fosfomycin, acriﬂavine, ethidium bromide, and
benzalkonium
entS 511145.b0591 Predicted transporter; exports the siderophore enterobactin out of the cell
soxS 511145.b4062 DNA-binding transcriptional dual regulator; transcriptional activator of the superoxide response regulon of E. coli that
includes at least 10 genes such as sodA, nfo, zwf, and micF. Binds the DNA sequence 5′-GCACN(7)CAA-3′. It also
facilitates the subsequent binding of RNA polymerase to the micF and the nfo promoters
ygiB 511145.b3037 Conserved outer membrane protein
acrA 511145.b0463 Multidrug efﬂux system; AcrAB is a drug efﬂux protein with a broad substrate speciﬁcity
mdtC 511145.b2076 Multidrug efﬂux system, subunit C; the mdtABC tri-partite complex confers resistance against novobiocin and
deoxycholate
macB 511145.b0879 Fused macrolide transporter subunits of ABC superfamily: ATP-binding component/membrane component; part of the
ABC transporter complex macAB involved in macrolide export. Trans-membrane domains (TMD) form a pore in the
inner membrane and the ATP-binding domain (NBD) is responsible for energy generation. Seems to confer resistance
against macrolides composed of 14- and 15-membered lactones but no or weak resistance against 16-membered ones
(probable)
acrR 511145.b0464 DNA-binding transcriptional repressor; potential regulator protein for the acrAB genes
mdtB 511145.b2075 Multidrug efﬂux system, subunit B; the mdtABC tri-partite complex confers resistance against novobiocin and
deoxycholate
macA 511145.b0878 Macrolide transporter subunit, membrane fusion protein (MFP) component; efﬂux transporter for macrolide antibiotics
emrA 511145.b2685 Multidrug efﬂux system; the emr locus confers resistance to substances of high hydrophobicity. EmrA probably
participate in a transport system to extrude toxins and drugs from the cell
btuB 511145.b3966 Vitamin B12/cobalamin outer membrane transporter; involved in the active translocation of vitamin B12 (cyanocobal-
amin) across the outer membrane to the periplasmic space. It derives its energy for transport by interacting with the
trans-periplasmic membrane protein tonB. Is also a receptor for bacteriophages BF23 and C1, and for A and E colicins
thiD 511145.b2103 Bifunctional hydroxy-methylpyrimidine kinase/hydroxy-phosphomethylpyrimidine kinase; catalyzes the phosphorylation
of HMP-P–HMP-PP
ttcA 511145.b1344 Predicted C32 tRNA thiolase; required for the thiolation of cytidine in position 32 of tRNA, to form 2-thiocytidine (s(2)C32;
by similarity)
fadL 511145.b2344 Long-chain fatty acid outer membrane transporter; Involved in translocation of long-chain fatty acids across the outer
membrane. It is a receptor for the bacteriophageT2. FadL may form a speciﬁc channel
marA 511145.b1531 DNA-binding transcriptional dual activator of multiple antibiotic resistance; may be a transcriptional activator of genes
involved in the multiple antibiotic resistance (Mar) phenotype. It can also activate genes such as sodA, zwf, and micF
acrE 511145.b3265 Cytoplasmic membrane lipoprotein; may affect speciﬁc membrane functions, such as septum formation during cell
division, and cell membrane permeability
acrD 511145.b2470 Aminoglycoside/multidrug efﬂux system; participates in the efﬂux of aminoglycosides. Confers resistance to a variety
of these substances
ompC 511145.b2215 Outermembrane porin protein C; forms passive diffusion poreswhich allow smallmolecularweight hydrophilicmaterials
across the outer membrane
ompW 511145.b1256 Outer membrane protein W; acts as a receptor for colicin S4
ybhS 511145.b0793 Predicted transporter subunit: membrane component of ABC superfamily
pgi 511145.b4025 Glucosephosphate isomerase
yﬁO 511145.b2595 Predicted lipoprotein
yqiB 511145.b3033 Predicted dehydrogenase
tolC 511145.b3035 Transport channel; required for proper expression of outer membrane protein genes such as ompF, nmpC, protein
2, hemolysin, colicin V, or colicin E1. May be specialized for signal sequence independent, extracellular secretion in
Gram-negative bacteria
yhdP 511145.b4472 Conserved membrane protein, predicted transporter
ygiC 511145.b3038 Predicted enzyme
(Continued)
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy September 2011 | Volume 2 | Article 189 | 12
Zgurskaya et al. Role of TolC in enterobacterial physiology
Table A1 | Continued
Gene name Gene number Function
rob 511145.b4396 DNA-binding transcriptional activator; binds to the right arm of the replication origin oriC of the chromosome. Rob binding
may inﬂuence the formation of the nucleoprotein structure, required for oriC function in the initiation of replication
emrK 511145.b2368 EmrKY–TolC multidrug resistance efﬂux pump, membrane fusion protein component
ompT 511145.b0565 DLP12 prophage; outer membrane protease VII (outer membrane protein 3b); protease that can cleave T7 RNA poly-
merase, ferric-enterobactin receptor protein (FEP), antimicrobial peptide protamine, and other proteins. This protease
has a speciﬁcity for paired basic residues
yqiA 511145.b3031 Predicted esterase; displays esterase activity toward palmitoyl-CoA and pNP-butyrate
thiC 511145.b3994 Thiamin (pyrimidine moiety) biosynthesis protein; required for the synthesis of the hydroxymethylpyrimidine (HMP)
moiety of thiamine (4-amino-2-methyl-5-hydroxymethylpyrimidine)
secE 511145.b3981 Preprotein translocase membrane subunit; essential for protein export
emrB 511145.b2686 Multidrug efﬂux system protein; translocase that confers resistance to substances of high hydrophobicity
ompF 511145.b0929 Outer membrane porin 1a (Ia;b;F); OmpF is a porin that forms passive diffusion pores which allow small molecular
weight hydrophilic materials across the outer membrane. It is also a receptor for the bacteriophageT2
parE 511145.b3030 DNA topoisomerase IV, subunit B; topoisomerase IV is essential for chromosome segregation. It has relaxation of
supercoiled DNA activity. Performs the decatenation events required during the replication of a circular DNA molecule
emrX 511145.b2367 Predicted multidrug efﬂux system
pcm 511145.b2743 l-isoaspartate protein carboxylmethyltransferase type II; catalyzes the methyl esteriﬁcation of l-isoaspartyl residues in
peptides and proteins that result from spontaneous decomposition of normal l-aspartyl and l-asparaginyl residues. It
plays a role in the repair and/or degradation of damaged proteins. This enzyme does not act on d-aspartyl residues
mdtF 511145.b3514 Multidrug transporter, RpoS-dependent; Part of a multidrug resistance efﬂux system that confers resistance to com-
pounds such as rhodamine 6G, erythromycin, doxorubicin, ethidium bromide, TPP, SDS, deoxycholate, crystal violet,
and benzalkonium
mdtA 511145.b2074 Multidrug efﬂux system, subunit A; the mdtABC tri-partite complex confers resistance against novobiocin and
deoxycholate
mdtE 511145.b3513 Multidrug resistance efﬂux transporter; part of a multidrug resistance efﬂux system that confers resistance to com-
pounds such as rhodamine 6G, erythromycin, doxorubicin, ethidium bromide, TPP, SDS, deoxycholate, crystal violet,
and benzalkonium
icc 511145.b3032 3′,5′ cAMP phosphodiesterase (EC:3.1.4.17); Affects the expression of the lacZ gene
tolB 511145.b0740 Periplasmic protein; Involved in the tonB-independent uptake of groupA colicins (colicinsA, E1, E2, E3, andK). Necessary
for the colicins to reach their respective targets after initial binding to the bacteria
acrF 511145.b3266 Multidrug efﬂux system protein; involved in cell envelope formation. Is produced in extremely low amounts
yfgC 511145.b2494 Predicted peptidase
yaeT 511145.b0177 Conserved protein; involved in the assembly of outer membrane proteins. Does not play a direct role in the export of
outer membrane lipids
phoP 511145.b1130 DNA-binding response regulator in two-component regulatory system with PhoQ; Member of the two-component
regulatory system phoQ/phoP involved in adaptation to low Mg(2+) environments and the control of acid resistance
genes. Mediates magnesium inﬂux to the cytosol by activation of mgtA. Promotes expression of the two-component
regulatory system rstA/rstB and transcription of the hemL, mgrB, nagA, slyB, vboR, and yrbL genes
acrB 511145.b0462 Multidrug efﬂux system protein; AcrAB is a drug efﬂux protein with a broad substrate speciﬁcity
ecfM 511145.b3096 Conserved protein
nfnB 511145.b0578 Dihydropteridine reductase, NAD(P)H-dependent, oxygen-insensitive; Reduction of a variety of nitroaromatic com-
pounds using NADH (and to lesser extent NADPH) as source of reducing equivalents; two electrons are transferred.
Capable of reducing nitrofurazone, quinones, and the anti-tumor agent CB1954 [5-(aziridin-1-yl)-2,4-dinitrobenzamide].
The reduction of CB1954 results in the generation of cytotoxic species
nudF 511145.b3034 ADP–ribose pyrophosphatase; acts on ADP–mannose; and ADP–glucose as well as ADP–ribose. Prevents glycogen
biosynthesis. The reaction catalyzed by this enzyme is a limiting step of the gluconeogenic process
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